This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and distribution of MenAfriVac®, the vaccine that has virtually eliminated meningitis A wherever it has been introduced.
Corporate author(s): PATH
Publication date: April 2017
403 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
See also: Vaccines and immunization > Meningitis
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA